反応式
[C:1]([C:5]1[CH:9]=[C:8]([NH:10][C:11]([NH:13][C:14]2[CH:19]=[CH:18][C:17]([Cl:20])=[CH:16][CH:15]=2)=[O:12])[N:7]([C:21]2[CH:22]=[C:23]([CH:29]=[CH:30][CH:31]=2)C(OCC)=O)[N:6]=1)([CH3:4])([CH3:3])[CH3:2].C[Mg]Br.[C:35]1([CH3:41])C=CC=C[CH:36]=1.C1C[O:45]CC1>C1COCC1>[C:1]([C:5]1[CH:9]=[C:8]([NH:10][C:11]([NH:13][C:14]2[CH:15]=[CH:16][C:17]([Cl:20])=[CH:18][CH:19]=2)=[O:12])[N:7]([C:21]2[CH:31]=[CH:30][CH:29]=[C:23]([C:35]([OH:45])([CH3:41])[CH3:36])[CH:22]=2)[N:6]=1)([CH3:4])([CH3:3])[CH3:2]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of Example C (220 mg, 0.5 mmol) in dry THF (20 mL) was added dropwise a solution of methyl magnesium bromide in toluene/THF (3.6 mL, 5.0 mmol) at −78° C. under N2. After stirring for 1 h, the mixture was allowed to rise to RT and stirred for another 2 h. The reaction mixture was quenched with saturated NH4Cl and aqueous HCl solution (10%), and extracted with ethyl acetate. The combined organic extracts were washed with brine, dried (Na2SO4), the solvent was removed in vacuo and the residue was purified by column chromatography to afford 1-{5-t-butyl-2-[3-(1-hydroxy-1-methyl-ethyl)-phenyl]-2H-pyrazol-3-yl}-3-(4-chloro-phenyl)-urea (174 mg, 81%). 1H NMR (DMSO-d6): 9.11 (s, 1H), 8.34 (s, 1H), 7.59 (s, 1H), 7.46 (t, J=8.8 Hz, 1H), 7.43-7.40 (m, 3H), 7.31-7.28 (m, 3H), 6.34 (s, 1H), 5.13 (s, 1H), 1.42 (s, 6H), 1.27 (s, 9H); MS (ESI) m/z: 428 (M+H+).
後処理
- customto rise to RT
- stirringstirred for another 2 h
- customThe reaction mixture was quenched with saturated NH4Cl and aqueous HCl solution (10%)
- extractionextracted with ethyl acetate
- washThe combined organic extracts were washed with brine
- dry with materialdried (Na2SO4)
- customthe solvent was removed in vacuo
- customthe residue was purified by column chromatography
出典と根拠
- ORDレコード
- ord-7c74fbbe13be42449700741559708bbe
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07737283B2
関連ノート
読み込み中…